Hospira is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™ through the right people and the right products.
As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Hospira is also a leading provider of contract manufacturing services to proprietary pharmaceutical and biotechnology companies for formulation development, filling and finishing of injectable pharmaceuticals. Its broad portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.
Through its offering of high-quality, lower-cost alternatives to proprietary medications, Hospira continues to help reduce the overall costs of healthcare — to improve both the affordability of care for patients and the financial strength of the global healthcare system. The company also is a pioneer in providing innovative solutions to improve patient and healthcare worker safety.
With a presence in the Middle East and North Africa hospital market for more than 50 years, Hospira ME & NA offers a wide range of products that is being expanded continuously. From its regional head office located in Dubai Hospira is running the regional commercial operations in more than 15 countries through assigned distributors. In ME & NA, Hospira is the market leader in Medication Management Systems, Drug Delivery Systems, I.V. Sets, Injectable Pharmaceuticals and Oncology Products.
By working with its customers to integrate technologies at the point of care, Hospira is the partner of choice for improving patient and workplace safety, clinical outcomes and cost management, and caregiver efficiency and effectiveness.
The name "Hospira" is derived from the words hospital, spirit, inspire and the Latin word spero, which means hope. It reflects the company's primary market focus and expresses the hope and optimism that are critical in the healthcare industry.
Hospira had 2010 sales of approximately US$3.9 billion and is headquartered north of Chicago in Lake Forest, Ill., USA.